What GHK-Cu adds to the formulation: Gene expression modulation across hundreds of genes including collagen genes (Type I, III), tissue inhibitors of metalloproteinases, anti-inflammatory mediators Collagen synthesis stimulation, specifically Type I and Type III collagen the structural proteins of skin, connective tissue, and many other tissues Anti-inflammatory signaling through investigated effects on TNF-, IL-6, and NF-B pathways Copper-peptide chemistry effects including cofactor activity for skin-relevant enzymes Skin-research and hair-research applications (the GHK-Cu literature in these areas is substantial) For the GHK-Cu deep-dive, see Copper Peptides Explained
NICE guideline NG28 recommends individualised HbA1c targets: typically 48 mmol/mol (6.5%) for adults with type 2 diabetes managed by diet and drugs that don't cause hypoglycaemia, and 53 mmol/mol (7.0%) for those on medicines that can cause hypoglycaemia (such as sulfonylureas or insulin)
Constipation warrants particular attention , as inadequate fluid intake combined with reduced gut motility may contribute to discomfort and, theoretically, could exacerbate pre-existing diverticular disease, though this has not been definitively established
For patients with type 2 diabetes, the American Diabetes Association (ADA) Standards of Care emphasize individualized glycemic targets and treatment selection based on patient-specific factors including baseline hemoglobin A1c (HbA1c), presence of atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease, hypoglycemia risk, weight considerations, and patient preferences
When you lose weight and a significant portion of that loss is muscle, you are getting lighter in a way that leaves you metabolically weaker
For example, An et al